About Ampyra (Prescription Drug)
Ampyra™ is the brand name for dalfampridine, an extended release formulation of 4-aminopyridine or 4-AP. Ampyra, a potassium channel blocker, is indicated as a treatment to improve walking in patients with multiple sclerosis.
Learn more about Ampyra in our Ampyra Community Report.
|20 mg Daily Jun 10, 2010 - Last Update|
Jul 12, 2010
EffectivenessCan’t tell (for Walking problems)
EffectivenessCan’t tell (for Unsteady gait)
Side effectsModerate (Chronic constipation, Dizziness (vertigo))
BurdenNot at all hard to take